GlassScriptPhysician profile
Joel A Aronowitz
NPI 1558407411
$1,628.20
in general payments reported to CMS, 2019-2025
22 companies · $26.91 in 2025
The $26.91 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $389 · 2021: $313 · 2022: $311 · 2023: $82.62 · 2024: $17.37 · 2025: $26.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $238.15 | 2019-2022 | |
| Allergan, INC. | $226.09 | 2019-2022 | |
| Organogenesis INC. | $222.19 | 2019-2021 | |
| Kci USA, INC. | $150.41 | 2019-2022 | |
| Abbvie INC. | $126.90 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Amniox Medical, INC. | $92.47 | 2020 | |
| Paratek Pharmaceuticals, INC. | $91.83 | 2019-2020 | |
| Integra Lifesciences Corporation | $61.54 | 2019-2022 | |
| Mentor Worldwide LLC | $59.17 | 2021 | |
| Misonix INC | $44.51 | 2021 | |
| Zimmer Biomet Holdings, INC. | $40.76 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $36.53 | 2019 | |
| Bioventus LLC | $34.24 | 2022 | |
| Sientra, INC. | $33.72 | 2021 | |
| Bsn Medical INC | $32.70 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $31.55 | 2020 | |
| Hartmann USA, INC. | $26.21 | 2022 | |
| Axogen | $21.25 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $21.08 | 2019 | |
| Merck Sharp & Dohme LLC | $15.41 | 2021 | |
| Galderma Laboratories, L.P. | $14.09 | 2022 | |
| Medela LLC | $7.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Aronowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.